- Patricio Massera, CEO, AGC Biologics
With the demand for pDNA growing at 20% (cagr), AGC Biologics is providing one more solution for our customers.
Leveraging our 25 years of experience in providing CDMO services, we are confident we will successfully serve the growing demand for pDNA.
Our Offering Includes:
pDNA supply in optional quantities for GMP or non-GMP purposes to be used as:
- DNA vaccine
- starting material for Lentivirus & Adeno Associated Virus
- starting material for RNA Drugs and cell-free protein production
We have successfully manufactured pDNA as vaccines for 10 years. Now is the time to expand our supply of pDNA to more applications.
Click to read our Press Release